A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...
Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026Full imaging and dosimetry data from MP0712 compassionate care program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback